drugset / Trial / NCT00346619
Determining the Amount of Time Needed for Nelfinavir to Boost the Immune System in Adults
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Our group has shown that HAART increases the thymic production of naïve T cells in the healthy adult, thereby boosting the immune system. We propose to investigate the amount of and length of Nelfinavir therapy necessary to increase those cells in adults. Subjects will be treated with Nelfinavir, and blood will be sampled at variable times to determine the immune response in peripheral blood.
Timeline
- Start
- 2005-10
- Primary completion
- 2007-10
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nelfinavir | Other / unclassified | 1250 mg | Oral |
Indications
No indication recorded.